| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |